Cellebrite DI (CLBT) Receivables - Other (2020 - 2025)

Cellebrite DI (CLBT) has reported Receivables - Other for 6 consecutive years, with $78.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Receivables - Other fell 3.41% year-over-year to $78.6 million; the TTM figure through Dec 2025 stood at $78.6 million (down 3.41% YoY), while the FY2025 annual figure was $78.6 million, down 3.41% from the prior year.
• Receivables - Other came in at $78.6 million for Q4 2025 at Cellebrite DI, down from $81.3 million in the prior quarter.
• The five-year high for Receivables - Other was $89.2 million in Q4 2023, with the low at $72.3 million in Q4 2021.
• Average Receivables - Other over 5 years is $80.6 million, with a median of $81.3 million recorded in 2024.
• Across the five-year window, Receivables - Other soared 113.13% in 2021 and declined 8.78% in 2024, its largest moves.
• Year by year, Receivables - Other stood at $72.3 million in 2021, then gained by 12.83% to $81.5 million in 2022, then increased by 9.38% to $89.2 million in 2023, then dropped by 8.78% to $81.3 million in 2024, then retreated by 3.41% to $78.6 million in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered $78.6 million, $81.3 million, and $89.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.